Alto Neuroscience Inc.

NYSE: ANRO · Real-Time Price · USD
2.35
0.05 (2.17%)
At close: Jun 27, 2025, 3:59 PM
2.38
1.50%
After-hours: Jun 27, 2025, 05:56 PM EDT
2.17%
Bid 2.1
Market Cap 63.48M
Revenue (ttm) n/a
Net Income (ttm) -63.18M
EPS (ttm) -2.3
PE Ratio (ttm) -1.02
Forward PE -0.84
Analyst Buy
Ask 2.5
Volume 310,269
Avg. Volume (20D) 265,167
Open 2.32
Previous Close 2.30
Day's Range 2.31 - 2.49
52-Week Range 1.60 - 17.55
Beta 1.93

About ANRO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANRO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ANRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 months ago
+25.56%
Alto Neuroscience shares are trading higher after ... Unlock content with Pro Subscription
8 months ago
-69.99%
Alto Neuroscience shares are trading lower after the company announced topline results from a Phase 2b trial evaluating ALTO-100 as a treatment for major depressed disorder did not meet its primary endpoint.